Covid-19 numbers can create public confusion over outcomes for the vaccinated

Simpler, clearer indicators can help the public interpret the sea of data on COVID-19 and avoid cognitive biases, says Duke-NUS’ David Matchar...

Read here (Channel News Asia, Nov 26, 2021)

Frustration with those who refuse Covid-19 vaccination but making it compulsory is tricky: Infectious diseases experts

Ramping up communications to convince those on the fence, along with differentiated measures nudging more to take the shot can help get vaccination rates up, say infectious diseases experts on CNA’s Heart of the Matter podcast...

‘As someone who treats COVID-19 patients, Dr David Lye, Director of the Infectious Disease Research and Training Office at the National Centre for Infectious Diseases (NCID), says he has spoken to “thousands of people”, and he always has one message for them: Get vaccinated. As a researcher and a scientist, he admits he gets frustrated when he encounters people medically able to get a vaccine but choose not to. But would he go so far as to recommend that vaccines be made compulsory?

“To be honest, I am in favour of a vaccine mandate, but I'm also aware that the impact on individuals in these times can be devastating,” Dr Lye added, pointing to the possibility of the unvaccinated getting shut out of jobs if COVID-19 vaccination was made compulsory nationally.

‘He was speaking to Supervising Editor Lin Suling, host of Heart of the Matter podcast on Thursday (Sep 16).

‘Dr Ashley St John, Associate Professor at Duke-NUS Medical School’s Programme in Emerging Infectious Diseases, who was also on the podcast, agreed. "If you're asking me personally, it would be nice to have compulsory COVID-19 vaccines, but I also understand there are other policy considerations … beyond just the scientific aspects.”

Read here (Channel News Asia, Sept 18, 2021)

G20 health ministers aim to vaccinate 40% of global population against Covid-19 by end-2021

‘Health Minister Ong Ye Kung and his counterparts from the Group of Twenty (G20) are aiming to vaccinate at least 40 per cent of the world against COVID-19 by the end of the year. The target was announced at the G20 Health Ministers’ Meeting, held from Sunday (Sep 5) to Monday in Rome.

‘In a press release on Monday, Singapore's Ministry of Health (MOH) said the meeting had also adopted a Health Ministers’ Declaration emphasising the importance of strong multilateral collaboration in managing the COVID-19 pandemic and supporting global recovery, with the World Health Organization (WHO) taking a central and leading role. The health ministers also agreed that vaccination was key.’

Read here (Channel News Asia, Sept 6, 2021)

Indonesia study finds China's Sinovac COVID-19 vaccine effective in medical staff

‘China's Sinovac Biotech COVID-19 vaccine was 98 per cent effective at preventing death and 96 per cent effective at preventing hospitalisation among a group of inoculated Indonesian medical staff, a study conducted by the country's health ministry has found.

‘The findings were based on data from 120,000 healthcare workers in Jakarta who had received the vaccine between January and March this year, lead researcher and health official Pandji Dhewantara told a briefing on Wednesday.’

Read here (Channel News Asia, May 12, 2021)

Antiseptic throat spray can reduce Covid-19 spread in high-risk settings, say Singapore researchers

‘A type of antiseptic throat spray, as well as an oral drug usually prescribed to treat malaria and arthritis, have been found to be effective in reducing the spread of COVID-19 in high-transmission settings, said Singapore researchers on Sunday (Apr 25).

‘The findings were made after a large-scale clinical trial conducted last May, involving more than 3,000 migrant workers living in Tuas South dormitory.

‘During the six-week trial, workers were given a povidone-iodine throat spray, which can be bought off the counter, and oral hydroxychloroquine, which requires a prescription.’

Read here (Channel News Asia, Apr 25, 2021)

How Covid-19 vaccines are being weaponised as countries jostle for influence

‘A new hybrid Cold War is underway, with US, China and pivotal states engaging in a power play, says NUS Business School’s Alex Capri...

‘[V]accine diplomacy has shed light on an even more fundamental truth: A hybrid cold war is underway, involving the US, China and other pivotal states. Its by-product is hybrid warfare, a mix of diplomatic, economic, cyber and information-related actions, all of which fall below the threshold of armed conflict but are, nonetheless, disruptive to the workings of the international system.

‘There will be no returning to the kind of globalisation the world experienced over the past four decades. Consequently, state and non-state actors must adapt.’

Read here (Channel News Asia, Apr 8, 2021)

AstraZeneca Covid-19 vaccine is ‘haram’, but permissible due to urgent situation: Indonesia Islamic body

‘Indonesia’s most influential Islamic organisation said AstraZeneca’s COVID-19 vaccine is “haram” or forbidden for Muslims, but its use can be temporarily permitted due to a lack of alternatives. The Indonesian Council of Ulema or MUI said it has conducted studies on the vaccine to see if it is “holy and halal” for Muslims to use.

‘The studies, said head of the council’s fatwa department Asorirun Niam Sholeh, showed that the AstraZeneca vaccine uses pork-derived trypsin – which is needed to break down proteins – in its production. Pork is considered unclean by Muslims.’  

Read here (Channel News Asia, Mar 19, 2021)

Malaysia PM Muhyiddin unveils RM20 billion economic stimulus package

‘Malaysian Prime Minister Muhyiddin Yassin announced a new economic stimulus package worth RM20 billion (US$4.8 billion) on Wednesday (Mar 17), one year after Malaysia first imposed a lockdown to curb the spread of COVID-19. This is the sixth package unveiled since the start of the COVID-19 pandemic.’

Read here (Channel News Asia, Mar 17, 2020)

Moderna begins study of Covid-19 vaccine in kids

‘Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday (Mar 16). The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart and intends to enrol about 6,750 children in the United States and Canada.’

Read here (Channel News Asia, Mar 16, 2021)

WHO approves J&J's COVID-19 vaccine for emergency listing

‘The World Health Organization on Friday (Mar 12) approved the emergency listing of Johnson & Johnson's COVID-19 vaccine, giving its seal of approval to expedite use especially in countries with weaker regulatory agencies. It is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO, and the first requiring just a single injection.’

Read here (Channel News Asia, Mar 13, 2021)

Oral Covid-19 treatment yields promising trial data: Drugmakers

‘German pharmaceutical giant Merck and a US partner reported promising results on Saturday (Mar 6) in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients' viral load...

‘In January, Merck halted work on two COVID-19 vaccine candidates but has pressed on with research into two products to treat the disease, including a pill-based one called molnupiravir, which it has developed with Ridgeback Biotherapeutics.

‘This drug caused a significant drop in patients' viral load after five days of treatment with it, Merck said at a meeting with infectious disease experts. This Phase 2A test - drug trials have three stages before a product can be approved - was carried out among 202 non-hospitalised people with symptoms of COVID-19.’

Read here (Channel News Asia, Mar 7, 2021)

Malaysia approves Sinovac, AstraZeneca Covid-19 vaccines for use

‘Malaysia on Tuesday (Mar 2) granted conditional approval for the use of vaccines made by UK firm AstraZeneca and China's Sinovac, just days after launching its nationwide COVID-19 inoculation programme. Malaysia began its vaccination drive on Feb 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.’

Read here (Channel News Asia, Mar 2, 2021)

Covid-19 infections falling worldwide but WHO warns against apathy

‘Reported daily coronavirus infections have been falling across the world for a month and on Tuesday (Feb 16) hit their lowest since mid-October, Reuters figures show, but health experts warned against apathy even as vaccines are being rolled out worldwide. Falls in infections and deaths coincide with lockdowns and severe curbs on gatherings and movement as governments weigh the need to stop successive waves of the pandemic with the need to get people back to work and children back to school.

‘But optimism over a way out of the crisis has been tempered by new variants of the virus, raising fears about the efficacy of vaccines. "Now is not the time to let your guard down," Maria Van Kerkhove, the World Health Organization's technical lead on COVID-19, told a briefing in Geneva.’

Read here (Channel News Asia, Feb 19, 2021) 

Inside poverty: How we gave a voice to Asia’s poor during Covid-19

‘When COVID-19 struck in 2020, sending many Asian countries into lockdown, CNA’s Insight series zoomed in on its impact on the poor - with teams on the ground in Indonesia, Malaysia, the Philippines, Bangladesh, India and Hong Kong. Poverty rates soared for the first time in almost two decades, dealing a blow to decades worth of poverty alleviation efforts.

‘With well over 100,000 views per episode, Poverty in Asia drew thousands of comments, ranging from words of encouragement for our profiles, to asking questions such as “is this poverty porn?” and “Why do the poor have so many children?”.

‘The producers behind the episodes, Aji Yahurti from Indonesia, Chen Yih Wen from Malaysia, Lolita Lachia from Philippines and Insight’s Ikhwan Adrian Rivai answer viewers’ questions and talk the about the challenges faced in recording the stories of the poor, amid a pandemic.

‘They also share about unexpected kindnesses and life lessons they learnt from those living in scarcity. One profile from the Philippines, Tricia Borromeo, had received $2,000 in donations to resume her university education, after the episode was released.’

View here (Channel News Asia video, Feb 18, 2021)

Israeli study finds 94% drop in symptomatic Covid-19 cases with Pfizer vaccine

‘Israel's largest healthcare provider on Sunday (Oct 14) reported a 94 per cent drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.

‘Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92 per cent less likely to develop severe illness from the virus.’

Read here (Channel News Asia, Feb 15, 2021)

WHO says all hypotheses still open in probe into COVID-19 origins

‘All hypotheses are still open in the World Health Organization's search for the origins of COVID-19, WHO Director-General Tedros Adhanom Ghebreyesus told a briefing on Friday (Feb 12), after Washington said it wants to review data from a WHO-led mission to China.

‘The mission, which spent four weeks in China looking into the origins of the COVID-19 outbreak, said this week that it was not looking further into the question of whether the virus escaped from a lab, which it considered highly unlikely.

‘The previous US administration of President Donald Trump, which left office last month, had said it suspected the virus may have escaped from a Chinese lab, which Beijing strongly denies.’

Read here (Channel News Asia, Feb 13, 2021)

Common asthma drug cuts Covid-19 hospitalisation risk, recovery time: Oxford study

‘A commonly used asthma treatment appears to reduce the need for hospitalisations as well as recovery time for COVID-19 patients if given within seven days of symptoms appearing, researchers at the University of Oxford said on Tuesday (Feb 9).

‘The findings were made following a mid-stage study of the steroid budesonide, sold as Pulmicort by AstraZeneca and also used for treating smoker's lung.

‘The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalisation by 90 per cent when compared with usual care, Oxford University said.’

Read here (Channel News Asia, Feb 10, 2021)

Covid-19 pandemic could last 4 to 5 years: Lawrence Wong

‘It may take four to five years before the COVID-19 pandemic ends and the world can look to a "post-COVID normal", said Education Minister Lawrence Wong on Monday (Jan 25). "At some point in time the pandemic will pass, but it may take four to five years before we finally see the end of the pandemic and the start of a post-COVID normal. What will this new post-COVID world look like? No one can tell," he said. Mr Wong, who co-chairs the COVID-19 multi-ministry taskforce, was speaking at the Singapore Perspectives 2021 conference hosted by the Institute of Policy Studies (IPS).’

Read here (Channel News Asia, Jan 25, 2021)

Independent Covid-19 review panel critical of China, WHO delays

‘An independent panel said on Monday (Jan 18) that Chinese officials could have applied public health measures more forcefully in January to curb the initial COVID-19 outbreak, and criticised the World Health Organization (WHO) for not declaring an international emergency until Jan 30.

‘The experts reviewing the global handling of the pandemic, led by former New Zealand Prime Minister Helen Clark and former Liberian President Ellen Johnson Sirleaf, called for reforms to the Geneva-based United Nations agency.’ 

Read here (Channel News Asia, Jan 19, 2021)

Covid-19 herd immunity unlikely in 2021 despite vaccines: UN

‘The World Health Organization’s chief scientist warned that even as numerous countries start rolling out vaccination programs to stop COVID-19, herd immunity is highly unlikely this year.

‘At a media briefing on Monday (Jan 11), Dr Soumya Swaminathan said it was critical countries and their populations maintain strict social distancing and other outbreak control measures for the foreseeable future. In recent weeks, Britain, the US, France, Canada, Germany, Israel, the Netherlands and others have begun vaccinating millions of their citizens against the coronavirus.’

Read here (Channel News Asia, Jan 12, 2021)